Skip to main content
Equibles
LMAT logo

LMAT · Lemaitre Vascular Inc · Documents

Track LMAT — free

Use LMAT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LMAT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$78.29 +0.64 (+0.82%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.79B
Shares
22.88M
Volume · Nov 13 200.09K Avg daily vol (3M) 288.13K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Aug 8
Quarterly report 10-Q FY2024 Q2, ended Jun 30
Quarterly report for FY2024 Q2
Revenue $55.85M ▲ 11.4% Net income $11.83M ▲ 46.0% Diluted EPS $0.52 ▲ 44.4%
May 10
Quarterly report 10-Q FY2024 Q1, ended Mar 31
Quarterly report for FY2024 Q1
Revenue $53.48M ▲ 13.6% Net income $9.89M ▲ 63.7% Diluted EPS $0.44 ▲ 63.0%
Feb 29
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $193.48M ▲ 19.7% Net income $30.11M ▲ 45.9% Diluted EPS $1.34 ▲ 44.1%
2023
Nov 7
Quarterly report 10-Q FY2023 Q3, ended Sep 30
Quarterly report for FY2023 Q3
Revenue $47.41M ▲ 21.5% Net income $7.5M ▲ 37.5% Diluted EPS $0.33 ▲ 32.0%
Aug 8
Quarterly report 10-Q FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Revenue $50.12M ▲ 19.0% Net income $8.1M ▲ 130.4% Diluted EPS $0.36 ▲ 125.0%
May 9
Quarterly report 10-Q FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Revenue $47.08M ▲ 19.0% Net income $6.04M ▲ unchanged Diluted EPS $0.27 ▲ unchanged
Mar 1
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $161.65M ▲ 4.7% Net income $20.64M ▼ 23.3% Diluted EPS $0.93 ▼ 25.6%
2022
Nov 8
Quarterly report 10-Q FY2022 Q3, ended Sep 30
Quarterly report for FY2022 Q3
Revenue $39.03M ▲ 1.7% Net income $5.46M ▼ 16.1% Diluted EPS $0.25 ▼ 16.7%
Aug 5
Quarterly report 10-Q FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Revenue $42.11M ▲ 3.5% Net income $3.52M ▼ 57.6% Diluted EPS $0.16 ▼ 60.0%
May 10
Quarterly report 10-Q FY2022 Q1, ended Mar 31
Quarterly report for FY2022 Q1
Revenue $39.56M ▲ 10.2% Net income $6.04M ▲ 1.8% Diluted EPS $0.27 ▼ 3.6%
Feb 28
Annual report 10-K FY2021, ended Dec 31
Annual report for FY2021
Revenue $154.42M ▲ 19.4% Net income $26.91M ▲ 26.8% Diluted EPS $1.25 ▲ 20.2%
2021
Nov 4
Quarterly report 10-Q FY2021 Q3, ended Sep 30
Quarterly report for FY2021 Q3
Revenue $38.37M ▲ 5.4% Net income $6.5M ▼ 13.4% Diluted EPS $0.30 ▼ 18.9%
Aug 5
Quarterly report 10-Q FY2021 Q2, ended Jun 30
Quarterly report for FY2021 Q2
Revenue $40.67M ▲ 63.7% Net income $8.3M ▲ 137.1% Diluted EPS $0.40 ▲ 135.3%
Showing 51–100 of 132 documents
Key facts CIK 1158895 CUSIP 525558201 13F (30d) 255 filings 226 filers Visit website Investor relations